Biophytis (EPA:ALBPS) | WebDisclosure

PRESS RELEASE

published on 10/30/2025 at 22:59, 7 months 23 days ago

Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports financial results for the first half of 2025, strategic update, and key achievements in sarcopenia and obesity. Plans for Phase 2 and Phase 3 studies outlined with focus on sustaining growth and value creation

Financial Results Biophytis Sarcopenia Strategic Update Obesity
BRIEF

published on 10/13/2025 at 07:05, 8 months 9 days ago

Biophytis et Partenaires Asiatiques Lancent un Essai Clinique Historique

Biophytis Essai Clinique Sarcopénie BIO101 Coentreprise Hong Kong
BRIEF

published on 10/13/2025 at 07:05, 8 months 9 days ago

Biophytis and Asian Investors to Launch Phase 3 Sarcopenia Trial

Biophytis Phase 3 Trial Sarcopenia BIO101 Asian Investors
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 8 months 9 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
BIOPHYTIS et un consortium d'investisseurs lancent le premier essai clinique de Phase 3 dans la sarcopénie, avec une coentreprise à Hong Kong et un investissement de 20 M$. Opérations cliniques prévues début 2026

Biophytis Investisseurs Essai Clinique Coentreprise Sarcopénie
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 8 months 9 days ago

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026

Biophytis Joint Venture Phase 3 Trial Sarcopenia Consortium Of Investors
PRESS RELEASE

published on 10/13/2025 at 06:59, 8 months 9 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong

Biophytis Essai Clinique Coentreprise Sarcopénie Consortium D'investisseurs
BRIEF

published on 09/30/2025 at 07:05, 8 months 22 days ago

Biophytis Renforce Sa Présence sur la Scène Internationale au 4ème Trimestre 2025

Biophytis Partenariats Sarcopénie Biotechnologies Événements Internationaux
BRIEF

published on 09/30/2025 at 07:05, 8 months 22 days ago

Biophytis to Engage in Key Events in Q4 2025

Biophytis Partnerships Longevity Sarcopenia Biotechnology Events
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 8 months 22 days ago

Biophytis to Participate in Four Key Events in Q4 2025
Biophytis to participate in four major international events in Q4 2025, showcasing its progress in transformative therapies impacting longevity and seeking new partnerships

Biophytis Partnerships Longevity International Events Transformative Therapies
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 8 months 22 days ago

Biophytis annonce sa participation à quatre événements clés au cours du 4ème trimestre 2025
Biophytis annonce sa participation à quatre événements clés internationaux au 4ème trimestre 2025 pour présenter ses avancées dans la santé et renforcer ses partenariats

Biophytis Développement Participation Événements Clés 4ème Trimestre 2025

Published on 06/23/2026 at 01:55, 10 minutes ago

Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 2 hours 40 minutes ago

Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 3 hours ago

Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 5 hours ago

RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 6 hours 20 minutes ago

Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly

View all ACCESSWIRE

Published on 06/23/2026 at 01:35, 30 minutes ago

DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 4 hours 58 minutes ago

EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 5 hours 15 minutes ago

Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 5 hours 33 minutes ago

EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 6 hours 38 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings

View all EQS

Published on 06/22/2026 at 18:45, 7 hours 20 minutes ago

Governance evolution
Published on 06/22/2026 at 18:45, 7 hours 20 minutes ago

ÉVOLUTION DE LA GOUVERNANCE
Published on 06/22/2026 at 18:16, 7 hours 48 minutes ago

ANTOINE FREY INCREASES HIS STAKE IN FREY
Published on 06/22/2026 at 18:16, 7 hours 48 minutes ago

ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 8 hours 5 minutes ago

GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION

View all LES ECHOS COMFI WIRE

News